← Leaderboards
Bruce Thomas Volpe
Feinstein Institute For Medical Research
$13,363,924
Attributed
$13,363,924
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2008–24$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$13,363,924 · 5
By mechanism
P01$13,363,924 · 5
Top collaborators
No co-investigators on record.
Most similar at Feinstein Institute For Medical Research
Same institution · by research overlap
- Betty Diamond$68,537,262
- Anne Davidson$18,272,977
- Patricio T Huerta$8,195,375
- Czeslawa Helena Kowal$3,133,957
- Sun Jung Kim$4,787,915
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsImpaired CognitionBrainBlood - Brain Barrier AnatomyNeuron LossBrain InjuriesCellsImpairmentCytokineHippocampus (Brain)ExhibitsExposure ToInjuryLipopolysaccharidesN-Methyl-D-Aspartate ReceptorsFunctional DisorderMouse ModelAntibodiesLupusAdultCognitiveFetalMediatingSerum
Grant awards (25)
Project 1 - Microglial activation in DNRAb-mediated brain pathology in mice$772,141
P01 · FY2024 · AI · contact PI
Project 1 - Microglial activation in DNRAb-mediated brain pathology in mice$904,394
P01 · FY2023 · AI · contact PI
Project 1 - Microglial activation in DNRAb-mediated brain pathology in mice$898,821
P01 · FY2022 · AI · contact PI
Project 1 - Microglial activation in DNRAb-mediated brain pathology in mice$945,319
P01 · FY2021 · AI · contact PI
Project 1 - Microglial activation in DNRAb-mediated brain pathology in mice$931,639
P01 · FY2020 · AI · contact PI
Modeling variable outcomes of antibody exposure$788,351
P01 · FY2018 · AI · contact PI
Nervous system alterations in sepsis-surviving mice$482,358
P01 · FY2018 · AI · contact PI
Histology Core$165,544
P01 · FY2018 · AI · contact PI
Modeling variable outcomes of antibody exposure$693,859
P01 · FY2017 · AI · contact PI
Nervous system alterations in sepsis-surviving mice$506,557
P01 · FY2017 · AI · contact PI
Histology Core$217,195
P01 · FY2017 · AI · contact PI
Modeling variable outcomes of antibody exposure$751,724
P01 · FY2016 · AI · contact PI
Nervous system alterations in sepsis-surviving mice$541,194
P01 · FY2016 · AI · contact PI
Histology Core$221,158
P01 · FY2016 · AI · contact PI
Modeling variable outcomes of antibody exposure$773,769
P01 · FY2015 · AI · contact PI
Nervous system alterations in sepsis-surviving mice$506,557
P01 · FY2015 · AI · contact PI
Histology Core$217,195
P01 · FY2015 · AI · contact PI
Modeling variable outcomes of antibody exposure$779,604
P01 · FY2014 · AI · contact PI
Nervous system alterations in sepsis-surviving mice$506,557
P01 · FY2014 · AI · contact PI
Histology Core$217,195
P01 · FY2014 · AI · contact PI
Developmental neurotoxicity: Maternal anti-NMDAR antibodies and fetal development$390,317
P01 · FY2012 · AI · contact PI
Developmental neurotoxicity: Maternal anti-NMDAR antibodies and fetal development$424,965
P01 · FY2011 · AI · contact PI
Developmental neurotoxicity: Maternal anti-NMDAR antibodies and fetal development$247,221
P01 · FY2010 · AI · contact PI
Developmental neurotoxicity: Maternal anti-NMDAR antibodies and fetal development$243,187
P01 · FY2009 · AI · contact PI
Developmental neurotoxicity: Maternal anti-NMDAR antibodies and fetal development$237,103
P01 · FY2008 · AI · contact PI